Drug · DIN 02173255 · Veterinary
CEFA-DRI
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 8, 2023; first marketed November 13, 2001.
- Drug Identification Number (DIN)
- 02173255
- Company (DIN owner)
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Suspension
- Route
- Intramammary
- Class
- Veterinary
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CEPHAPIRIN (CEPHAPIRIN BENZATHINE) | 300 MG | 10 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 18, 2025: NOC 36390Supplement to a New Drug Submission (SNDS) · Change in the manufacturing process for the drug substance, upgrades for sterility assurance
- September 8, 2023: NOC 31579Supplement to a New Drug Submission (SNDS) · Change in the specification for the drug product tests and replacement of the primary container closure system.
- June 15, 2021: NOC 26075New Drug Submission (NDS) · Administrative - Change in Product Ownership
- August 13, 2020: NOC 24028Supplement to a New Drug Submission (SNDS) · Manufacturing change
- June 16, 2010: NOC 11516New Drug Submission (NDS) · Change in ownership
- June 16, 2009: NOC 10253Supplement to a New Drug Submission (SNDS) · Alternate source of active ingredient
- June 27, 2003: NOC 3487New Drug Submission (NDS)
- November 3, 1995: NOC 7027New Drug Submission (NDS)